Novelix Pharmaceuticals schedules 32nd AGM for September 30, 2026

scanx
Reviewed by
Naman SScanX News Team
Key Highlights
  • Novelix Pharmaceuticals schedules its 32nd AGM for September 30, 2026
  • The meeting will be held via Video Conferencing/OAVM
  • Book closure runs from September 24 to September 30, 2026
  • Remote e-voting is open from September 27 to September 29, 2026
powered bylight_fuzz_icon
49706518

*this image is generated using AI for illustrative purposes only.

Novelix Pharmaceuticals Limited has scheduled its 32nd Annual General Meeting for September 30, 2026. The meeting will be conducted through Video Conferencing or Other Audio Visual Means (OAVM) in compliance with the Companies Act, 2013.

The company announced the details in a communication to the BSE dated August 31, 2026. The Board of Directors fixed the cut-off date for determining voting eligibility as September 23, 2026.

Meeting and Voting Details

The Register of Members and Share Transfer Books will remain closed from September 24, 2026, to September 30, 2026. This closure ensures the determination of shareholders eligible to attend and vote at the AGM.

Remote e-voting will be available for shareholders who wish to cast their votes before the meeting. The e-voting period begins on September 27, 2026, at 9:00 am and ends on September 29, 2026, at 5:00 pm.

Event Date Time
Cut-off date for voting eligibility September 23, 2026 N/A
Book closure start September 24, 2026 N/A
Remote e-voting start September 27, 2026 9:00 am
Remote e-voting end September 29, 2026 5:00 pm
AGM Date September 30, 2026 3:00 pm

The company, formerly known as Trimurthi Limited, is headquartered in Hyderabad, Telangana. Venkateshwarlu Pulluru, Whole-time Director, signed the intimation.

Historical Stock Returns for Trimurthi

1 Day5 Days1 Month6 Months1 Year5 Years
-3.54%+0.84%+10.54%+30.64%+92.68%0.0%

What key financial results or strategic initiatives is Novelix expected to present to shareholders at the upcoming AGM?

How might the company's recent performance in the pharmaceutical sector influence shareholder voting patterns on executive compensation or dividend proposals?

Are there any anticipated changes to the Board of Directors or management structure that will be discussed during the meeting?

Novelix appoints Gnana Prakash Gattu as whole time director

scanx
Reviewed by
Naman SScanX News Team
Key Highlights
  • Novelix appoints Gnana Prakash Gattu as Whole Time Director for five years
  • Effective date is August 29, 2026, subject to AGM approval
  • Gattu has 25+ years experience in management and IT
  • Appointment filed with BSE on August 31, 2026
powered bylight_fuzz_icon
49211050

*this image is generated using AI for illustrative purposes only.

Novelix Pharmaceuticals appointed Mr. Gnana Prakash Gattu as Whole Time Director for a five-year term, effective August 29, 2026. The Board approved the move during its meeting on that date, pending shareholder ratification at the upcoming Annual General Meeting.

The appointment was formalized in a filing to BSE Limited on August 31, 2026, under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The notice was signed by Venkateshwarlu Pulluru, the company’s existing Whole-time Director.

Appointment Details

Mr. Gattu (DIN: 00517921) joins the management team with immediate effect from August 29, 2026. His tenure is fixed for five years, subject to approval by members at the ensuing AGM.

Key details of the appointment include:

  • Profile: Graduate from IIT-Chennai with over 25 years of experience in management and information technology.
  • Relationship: Belongs to the Promoters and Promoter group. Not related to any other Directors or Key Managerial Personnel.
  • Other Directorships: Holds no directorship in other listed entities.
  • Regulatory Status: Not debarred from holding office by SEBI or any other authority.

AGM and Corporate Governance

The 32nd AGM remains scheduled for Wednesday, September 30, 2026, at 3:00 pm via Video Conferencing or Other Audio Visual Means (OAVM). This meeting will serve as the forum for shareholders to approve Mr. Gattu’s appointment.

Logistical details for shareholders remain unchanged:

  • Register Closure: September 24, 2026, to September 30, 2026.
  • Voting Cut-off: September 23, 2026.
  • Scrutinizer: M/s. Bharat Khaniwal & Co., Practicing Company Secretary (Membership No.: A29085).

The Board also approved the financial results and Board Report for FY26 during the August 29 meeting, which concluded at 4:55 pm.

Historical Stock Returns for Trimurthi

1 Day5 Days1 Month6 Months1 Year5 Years
-3.54%+0.84%+10.54%+30.64%+92.68%0.0%

How might Mr. Gattu's extensive IT and management background influence Novelix Pharmaceuticals' digital transformation or operational efficiency strategies?

What specific strategic initiatives is the board prioritizing for FY27 that necessitated this leadership change during a five-year tenure?

Could the appointment of a promoter-group member as Whole Time Director signal a shift in corporate governance dynamics or family involvement in daily operations?

More News on Trimurthi

1 Year Returns:+92.68%